Introduction
Drospirenone + estetrol is a combination hormonal contraceptive used to prevent pregnancy. Drospirenone is a progestin, and estetrol is an estrogen. This combination provides effective birth control by mimicking the natural menstrual cycle and regulating hormonal levels.
Uses
The primary use of drospirenone + estetrol is for:
- Contraception: Prevention of pregnancy in women of reproductive age.
Mechanism of Action
Drospirenone + estetrol works through several mechanisms:
- Suppressing ovulation: Both drospirenone and estetrol inhibit the release of eggs from the ovaries.
- Thickening cervical mucus: Drospirenone increases the viscosity of cervical mucus, making it more difficult for sperm to enter the uterus.
- Altering the endometrial lining: The combination affects the uterine lining, making it less suitable for implantation of a fertilized egg.
How Long Does It Take to Work?
When taken as directed, drospirenone + estetrol begins to provide contraceptive protection after 7 days of continuous use. It is recommended to use an additional contraceptive method during the first week of use if starting the regimen or if a dose is missed.
Absorption
Drospirenone and estetrol are absorbed from the gastrointestinal tract. Estetrol has good oral bioavailability, while drospirenone is well-absorbed with peak plasma levels typically reached within a few hours of ingestion.
Route of Elimination
Drospirenone and estetrol are metabolized primarily in the liver. Drospirenone is excreted in the urine and feces, while estetrol is mainly excreted in the urine. Both drugs undergo extensive first-pass metabolism in the liver.
Dosage
The recommended dosage of is one tablet daily for 28 consecutive days: one pink active tablet daily at the same time during the first 24 days followed by one white inactive tablet daily during the 4 following days.Instruction for missed doses-
If one pink active tablet is missed: Take the missed tablet as soon as possible and take the next tablet at the scheduled time, even if two active tablets are taken in one day. Continue taking one tablet a day until the pack is finished.
If two or more pink active tablets are missed in Week 1 or Week 2: Take one missed tablet as soon as possible and take the tablet for the current day (that means taking two tablets in one day) and discard the other missed tablets. Continue taking one tablet a day until the pack is finished. Use additional non-hormonal contraception as back-up until pink tablets have been taken for 7 consecutive days.
If two pink active tablets are missed in Week 3: Take one missed tablet as soon as possible and take the tablet for the current day (that means taking two tablets in one day) and discard the other missed tablets. Finish the active tablets and discard the inactive tablets in the pack. Start a new pack of tablets the next day. Use additional non-hormonal contraception as back-up until pink tablets have been taken for 7 consecutive days.
If one or more white inert tablets are missed: Skip the missed pill days and continue taking one tablet a day until the pack is finished.
Administration recommendations after vomiting or acute Diarrhea: If vomiting or acute diarrhea occurs within 3 to 4 hours after taking an active tablet, take the new active tablet (scheduled for the next day) as soon as possible. Take the new tablet within 12 hours of the usual time of tablet-taking if possible. If more than two tablets are missed, follow the advice concerning missed tablets, including using backup non hormonal contraception.
The standard dosage for drospirenone + estetrol is one tablet taken orally once daily. It is typically administered for a 21-day cycle followed by a 7-day break or placebo interval. The exact dosage and cycle length may vary based on the specific product formulation and patient needs.
Administration
Drospirenone + estetrol should be taken orally at the same time each day. It can be taken with or without food. Adherence to the daily regimen is crucial for maximum effectiveness. In the event of a missed dose, instructions should be followed as per the product labeling.
Side Effects
Common side effects of drospirenone + estetrol include:
- Nausea.
- Headache.
- Breast tenderness.
- Weight gain.
- Mood changes.
- Increased risk of blood clots.
- Stroke or heart attack.
- Severe liver dysfunction.
Toxicity
Toxicity from an overdose of drospirenone + estetrol may include severe nausea, vomiting, or breakthrough bleeding. Acute toxicity is rare but may require supportive care and symptomatic treatment.
Precautions
Precautions include:
- Monitoring for signs of thrombosis or embolism, especially in women with risk factors.
- Regular monitoring of liver function if there is a history of liver disease.
- Discontinuation or avoidance in the presence of certain contraindications such as uncontrolled hypertension or certain cancers.
Interaction
Drospirenone + estetrol may interact with other medications that affect hormonal levels or liver enzymes. Drugs such as antiepileptics, certain antibiotics, and antiretrovirals can reduce the effectiveness of hormonal contraceptives. It is important to inform healthcare providers of all concurrent medications.
Disease Interaction
Use with caution in individuals with a history of cardiovascular disease, liver disorders, or certain types of cancer (e.g., breast cancer). Regular medical evaluations are necessary to monitor for potential adverse effects related to these conditions.
Drug Interaction
Drug interactions may occur with medications that induce or inhibit liver enzymes, such as CYP3A4 inhibitors or inducers. Potential interactions should be reviewed with a healthcare provider to ensure proper contraceptive efficacy and avoid potential side effects.
Food Interactions
There are no specific food interactions with drospirenone + estetrol. The medication can be taken with or without food, and dietary intake does not significantly affect its absorption or effectiveness.
Pregnancy Use
Drospirenone + estetrol is contraindicated during pregnancy. If pregnancy occurs while using this contraceptive, it should be discontinued immediately, and a healthcare provider should be consulted for appropriate prenatal care.
Lactation Use
Drospirenone + estetrol is generally not recommended during breastfeeding as it may affect milk production and composition. Alternatives for contraception during lactation should be discussed with a healthcare provider.
Acute Overdose
Acute overdose of drospirenone + estetrol may cause nausea, vomiting, or breakthrough bleeding. There is no specific antidote, but supportive treatment should be provided, and the patient should be monitored for any severe symptoms.
Contraindication
Drospirenone + estetrol is contraindicated in:
- Women with a history of thrombosis or thromboembolic disorders.
- Severe liver disease or tumors.
- Uncontrolled hypertension.
- Certain types of cancer, such as hormone-sensitive cancers.
Use Direction
The medication should be used according to the prescribed regimen. It is important to take one tablet daily at the same time each day for the entire cycle. Missed doses should be managed according to the instructions provided with the medication.
Storage Conditions
Drospirenone + estetrol should be stored at room temperature, away from moisture and heat. The medication should be kept in its original packaging and out of reach of children. Check the expiration date regularly and properly dispose of expired or unused tablets.
Volume of Distribution
The volume of distribution for drospirenone and estetrol is not typically specified in the clinical literature but is considered in pharmacokinetic studies.
Half Life
The half-life of drospirenone is approximately 30 hours, while estetrol has a half-life of about 5 to 8 hours. These pharmacokinetic properties influence the dosing regimen and effectiveness of the contraceptive.
Clearance
Drospirenone and estetrol are primarily cleared through hepatic metabolism. Drospirenone is excreted in the urine and feces, while estetrol is mainly excreted in the urine. Clearance rates can be influenced by liver function and other individual patient factors.
